European Organisation for Research and Treatment of Cancer (EORTC) shared a post on LinkedIn:
“EORTC is proud to be part of this important consortium! Looking forward to the impact of the SISAQOL-IMI recommendations on improving the quality and consistency of Patient-Reported Outcome (PRO) data in cancer research.
Get insights into SISAQOL-IMI’s purpose and outcomes through this video interview with Madeline Pe, Head of the EORTC Quality of Life Department and co-leader of the SISAQOL-IMI Management and coordination Work Package.”
More posts featuring EORTC.